Skip to content
Spa Intelligence

Try a real question: “Who can inject Botox in Montana?” or “Is $12 per unit the full price?” The index loads on first use; what you type is matched in this browser.

Exosome products

Exosome products (category)

Various (category entry)

Not FDA-approvedChecked Sep 14, 2026 · Read on the pages cited

What it is

Maker
Various (category entry)
Category
Exosome products
Also called
exosomes, exosome facial, exosome therapy, stem cell exosomes

FDA status

Pathway
Not FDA-approved
First approved or cleared
None on record

Research notes

Category entry, not a single brand. Both FDA pages state there are no FDA-approved exosome products. The opened FDA pages do not specifically address cosmetic or topical 'exosome' skincare applied during facials or after microneedling, so this entry does not claim how FDA classifies any particular spa exosome serum; it records only that no exosome product is FDA-approved. FDA has issued warning letters to firms marketing exosome products (seen in search results, not opened).

What it’s authorized for

No FDA-authorized use is recorded.

How it’s sold

How it’s sold isn’t recorded for this entry.

What the label warns about

No label warning is recorded here. That isn’t the same as the label having none — the research notes and sources say what was opened.

Checking it’s the real thing

  • FDA consumer alert: "There are currently no FDA-approved exosome products." FDA warns that many regenerative medicine products are marketed illegally without being shown safe or effective, and advises asking whether FDA has reviewed a treatment (page content current as of 2024-04-09).

    FDA: Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes (opens in a new tab) · published Jul 22, 2020 · checked Sep 14, 2026

  • FDA public safety notification: FDA received reports of serious adverse events in patients in Nebraska treated with unapproved products marketed as containing exosomes. FDA states exosomes used to treat diseases and conditions in humans are regulated as drugs and biological products, and advises asking for the FDA IND number before treatment.

    FDA: Public Safety Notification on Exosome Products (opens in a new tab) · published Dec 6, 2019 · checked Sep 14, 2026

Ask in the room

“What’s the brand name printed on the box, vial or device panel — and may I see it?”

Recalls and enforcement

FDA recall and enforcement records filed under this product’s FDA number, read live from openFDA. A recall usually covers particular models or lots, not every unit ever made.

Searching FDA recall and enforcement records by this product’s FDA number…

What changed at the source

Dated FDA records that concern Exosome products (category), newest first. A record says what happened at the source; it is not a finding about any clinic's stock.

  1. Enforcement or recall ·

    FDA warning letter to a stem cell clinic that also marketed exosomes

    U.S. Food & Drug Administration · FDA warning letter 712579

    A CBER warning letter dated February 11, 2026 addressed an umbilical cord-derived stem cell product marketed without approval. The same letter noted that the company's website also marketed exosomes.

    What this source establishes
    That FDA treated this company's products, as marketed, as unapproved biological products.
    What it does not establish
    Anything about the specific exosome product a spa uses; the letter concerns one company's products and claims.

    The official record (opens in a new tab) · checked Sep 25, 2026

Check it yourself

Novel-product proof ladder: Marketing uses exosome, regenerative, stem-cell, biologic, or other novel-product language. Work down in order — each step needs the one before it.

  1. Name the productGet manufacturer, exact product name, and label or packaging.
  2. Name the claimSeparate a cosmetic appearance claim from a claim to treat, cure, or change a disease or condition.
  3. Ask for regulatory statusIf approval or an IND is claimed, ask for the exact record or IND number rather than a verbal assurance.Public Safety Notification on Exosome Products (opens in a new tab) · U.S. Food & Drug Administration
  4. Name deliveryTopical application, injection, or delivery through or with a device are different facts.
  5. Keep the unknownIf the product or status cannot be named, the desk records that gap instead of substituting a conclusion.

Worth knowing

What an FDA record can and can’t tell you

FDA records show what was authorized, for what, and when.

They can’t show that the product in the room is authentic, in date, stored properly, or being used for its authorized purpose. Those are questions for the room.

Sources

  1. FDA: Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes (opens in a new tab)FDA notice
  2. FDA: Public Safety Notification on Exosome Products (opens in a new tab)FDA notice

Checked Sep 14, 2026 · Read on the pages cited.

Treatments that use it

Product identity

Told a name? Shown a box?

Type what was said or printed, see whether it matches a registry entry, and note what you saw in your booking file.

Check a name